240 related articles for article (PubMed ID: 26163797)
1. MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia.
Gentner B; Pochert N; Rouhi A; Boccalatte F; Plati T; Berg T; Sun SM; Mah SM; Mirkovic-Hösle M; Ruschmann J; Muranyi A; Leierseder S; Argiropoulos B; Starczynowski DT; Karsan A; Heuser M; Hogge D; Camargo FD; Engelhardt S; Döhner H; Buske C; Jongen-Lavrencic M; Naldini L; Humphries RK; Kuchenbauer F
Exp Hematol; 2015 Oct; 43(10):858-868.e7. PubMed ID: 26163797
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of miR-99a is associated with poor prognosis of acute myeloid leukemia and promotes myeloid leukemia cell expansion.
Si X; Zhang X; Hao X; Li Y; Chen Z; Ding Y; Shi H; Bai J; Gao Y; Cheng T; Yang FC; Zhou Y
Oncotarget; 2016 Nov; 7(47):78095-78109. PubMed ID: 27801668
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia cells secrete microRNA-4532-containing exosomes to mediate normal hematopoiesis in hematopoietic stem cells by activating the LDOC1-dependent STAT3 signaling pathway.
Zhao C; Du F; Zhao Y; Wang S; Qi L
Stem Cell Res Ther; 2019 Dec; 10(1):384. PubMed ID: 31842997
[TBL] [Abstract][Full Text] [Related]
5. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
[TBL] [Abstract][Full Text] [Related]
6. Low expression of miR-204 is associated with expression of CD34 and poor performance status in denovo AML.
Abdelhafiz AS; Elsayed GM; Saber MM; Gameel A; Hamdy N
Int J Lab Hematol; 2020 Jun; 42(3):263-269. PubMed ID: 32048789
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
8. microRNA-1246-containing extracellular vesicles from acute myeloid leukemia cells promote the survival of leukemia stem cells via the LRIG1-meditated STAT3 pathway.
Chen L; Guo Z; Zhou Y; Ni J; Zhu J; Fan X; Chen X; Liu Y; Li Z; Zhou H
Aging (Albany NY); 2021 Apr; 13(10):13644-13662. PubMed ID: 33893245
[TBL] [Abstract][Full Text] [Related]
9. The molecular signature of AML with increased ALDH activity suggests a stem cell origin.
Blume R; Rempel E; Manta L; Saeed BR; Wang W; Raffel S; Ermakova O; Eckstein V; Benes V; Trumpp A; Ho AD; Lutz C
Leuk Lymphoma; 2018 Sep; 59(9):2201-2210. PubMed ID: 29334844
[TBL] [Abstract][Full Text] [Related]
10. Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.
Hickey CJ; Schwind S; Radomska HS; Dorrance AM; Santhanam R; Mishra A; Wu YZ; Alachkar H; Maharry K; Nicolet D; Mrózek K; Walker A; Eiring AM; Whitman SP; Becker H; Perrotti D; Wu LC; Zhao X; Fehniger TA; Vij R; Byrd JC; Blum W; Lee LJ; Caligiuri MA; Bloomfield CD; Garzon R; Marcucci G
Blood; 2013 Jan; 121(1):159-69. PubMed ID: 23100311
[TBL] [Abstract][Full Text] [Related]
11. The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia.
Gong JN; Yu J; Lin HS; Zhang XH; Yin XL; Xiao Z; Wang F; Wang XS; Su R; Shen C; Zhao HL; Ma YN; Zhang JW
Cell Death Differ; 2014 Jan; 21(1):100-12. PubMed ID: 24076586
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-150 expression induces myeloid differentiation of human acute leukemia cells and normal hematopoietic progenitors.
Morris VA; Zhang A; Yang T; Stirewalt DL; Ramamurthy R; Meshinchi S; Oehler VG
PLoS One; 2013; 8(9):e75815. PubMed ID: 24086639
[TBL] [Abstract][Full Text] [Related]
13. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice.
Ailles LE; Gerhard B; Kawagoe H; Hogge DE
Blood; 1999 Sep; 94(5):1761-72. PubMed ID: 10477702
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-34a-mediated death of acute myeloid leukemia stem cells through apoptosis induction and exosome shedding inhibition via histone deacetylase 2 targeting.
Hu Y; Ma X; Wu Z; Nong Q; Liu F; Wang Y; Dong M
IUBMB Life; 2020 Jul; 72(7):1481-1490. PubMed ID: 32181973
[TBL] [Abstract][Full Text] [Related]
15. Identification of T-lymphocytic leukemia-initiating stem cells residing in a small subset of patients with acute myeloid leukemic disease.
Risueño RM; Campbell CJ; Dingwall S; Levadoux-Martin M; Leber B; Xenocostas A; Bhatia M
Blood; 2011 Jun; 117(26):7112-20. PubMed ID: 21562049
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia.
De Luca L; Trino S; Laurenzana I; Tagliaferri D; Falco G; Grieco V; Bianchino G; Nozza F; Campia V; D'Alessio F; La Rocca F; Caivano A; Villani O; Cilloni D; Musto P; Del Vecchio L
Cell Death Dis; 2017 Jun; 8(6):e2849. PubMed ID: 28569789
[TBL] [Abstract][Full Text] [Related]
17. Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia.
Bhayadia R; Krowiorz K; Haetscher N; Jammal R; Emmrich S; Obulkasim A; Fiedler J; Schwarzer A; Rouhi A; Heuser M; Wingert S; Bothur S; Döhner K; Mätzig T; Ng M; Reinhardt D; Döhner H; Zwaan CM; van den Heuvel Eibrink M; Heckl D; Fornerod M; Thum T; Humphries RK; Rieger MA; Kuchenbauer F; Klusmann JH
J Clin Oncol; 2018 Apr; 36(10):1007-1016. PubMed ID: 29432078
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia.
Waclawiczek A; Hamilton A; Rouault-Pierre K; Abarrategi A; Albornoz MG; Miraki-Moud F; Bah N; Gribben J; Fitzgibbon J; Taussig D; Bonnet D
J Clin Invest; 2020 Jun; 130(6):3038-3050. PubMed ID: 32364536
[TBL] [Abstract][Full Text] [Related]
19. BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cells.
Kawabata KC; Zong H; Meydan C; Wyman S; Wouters BJ; Sugita M; Goswami S; Albert M; Yip W; Roboz GJ; Chen Z; Delwel R; Carroll M; Mason CE; Melnick A; Guzman ML
Blood; 2021 Feb; 137(6):812-825. PubMed ID: 32911532
[TBL] [Abstract][Full Text] [Related]
20. Physiological expression of miR-130a during differentiation of CD34
Mammoli F; Parenti S; Lomiento M; Gemelli C; Atene CG; Grande A; Corradini R; Manicardi A; Fantini S; Zanocco-Marani T; Ferrari S
Exp Cell Res; 2019 Sep; 382(1):111445. PubMed ID: 31152707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
